Prostatic Hyperplasia [clinicaltrials_resource:65576df4c137eb00cbf79efe3af11147]
Medical Therapy of Prostatic Symptoms (MTOPS) [clinicaltrials:NCT00021814]Clinical Trial in Males With BPH (Enlarged Prostate) [clinicaltrials:NCT00029822]A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). [clinicaltrials:NCT00044226]clinicaltrials:NCT00090103Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) [clinicaltrials:NCT00116571]Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) [clinicaltrials:NCT00169585]ALF-ONE : ALFuzosin ONcE Daily [clinicaltrials:NCT00280605]ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH [clinicaltrials:NCT00290030]Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS [clinicaltrials:NCT00316732]clinicaltrials:NCT00368979Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia [clinicaltrials:NCT00399464]Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin [clinicaltrials:NCT00401661]Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms [clinicaltrials:NCT00408954]Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study [clinicaltrials:NCT00427882]ALF-STONE: Alfuzosin in Uretheric Stones [clinicaltrials:NCT00454402]Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. [clinicaltrials:NCT00457457]SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin [clinicaltrials:NCT00486785]The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients [clinicaltrials:NCT00497939]clinicaltrials:NCT00510406Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS [clinicaltrials:NCT00517179]clinicaltrials:NCT00527605Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems [clinicaltrials:NCT00547625]Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up [clinicaltrials:NCT00563485]Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up [clinicaltrials:NCT00563654]clinicaltrials:NCT00596011clinicaltrials:NCT00793819A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 [clinicaltrials:NCT00814736]Prostate Mechanical Imager (PMI) Clinical Bridging Study [clinicaltrials:NCT00822952]MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment [clinicaltrials:NCT00885027]Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia [clinicaltrials:NCT00969072]clinicaltrials:NCT01003886MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use [clinicaltrials:NCT01050465]Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP) [clinicaltrials:NCT01108367]clinicaltrials:NCT01254071clinicaltrials:NCT01262989A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy [clinicaltrials:NCT01275521]clinicaltrials:NCT01294592clinicaltrials:NCT01299571Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan [clinicaltrials:NCT01323998]clinicaltrials:NCT01330303
condition [clinicaltrials_vocabulary:condition]
Medical Therapy of Prostatic Symptoms (MTOPS) [clinicaltrials:NCT00021814]Clinical Trial in Males With BPH (Enlarged Prostate) [clinicaltrials:NCT00029822]Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) [clinicaltrials:NCT00037141]Saw Palmetto Extract in Benign Prostatic Hyperplasia [clinicaltrials:NCT00037154]A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). [clinicaltrials:NCT00044226]Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels [clinicaltrials:NCT00062790]Minimally Invasive Surgical Therapy for BPH [clinicaltrials:NCT00064649]Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia [clinicaltrials:NCT00077012]clinicaltrials:NCT00090103Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice [clinicaltrials:NCT00111592]Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) [clinicaltrials:NCT00116571]A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) [clinicaltrials:NCT00127179]Kinetics of the Finasteride Prostate Induced Apoptosis [clinicaltrials:NCT00130767]Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH) [clinicaltrials:NCT00143221]Laser Prostatectomy Database and Registry [clinicaltrials:NCT00159406]Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) [clinicaltrials:NCT00169585]Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate [clinicaltrials:NCT00169767]Questioning Patients About Adverse Medical Events: A Randomized Controlled Trial [clinicaltrials:NCT00187616]clinicaltrials:NCT00194675Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP) [clinicaltrials:NCT00199550]clinicaltrials:NCT00224107clinicaltrials:NCT00224120clinicaltrials:NCT00224133Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia [clinicaltrials:NCT00237536]Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED) [clinicaltrials:NCT00256399]Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP) [clinicaltrials:NCT00274417]ALF-ONE : ALFuzosin ONcE Daily [clinicaltrials:NCT00280605]clinicaltrials:NCT00284518ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH [clinicaltrials:NCT00290030]Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection [clinicaltrials:NCT00303654]Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS [clinicaltrials:NCT00316732]Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH [clinicaltrials:NCT00347061]Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH [clinicaltrials:NCT00359905]A Prospective Evaluation of the GreenLight Model 120 Laser [clinicaltrials:NCT00364585]clinicaltrials:NCT00368979Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer [clinicaltrials:NCT00375765]A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. [clinicaltrials:NCT00379067]Study of the Effects of Pomegranate Tablets on Enlarged Prostates [clinicaltrials:NCT00381108]Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H) [clinicaltrials:NCT00382356]clinicaltrials:NCT00384930
condition browse [clinicaltrials_vocabulary:condition-browse]
Medical Therapy of Prostatic Symptoms (MTOPS) [clinicaltrials:NCT00021814]Clinical Trial in Males With BPH (Enlarged Prostate) [clinicaltrials:NCT00029822]Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) [clinicaltrials:NCT00037141]Saw Palmetto Extract in Benign Prostatic Hyperplasia [clinicaltrials:NCT00037154]A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). [clinicaltrials:NCT00044226]Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels [clinicaltrials:NCT00062790]Minimally Invasive Surgical Therapy for BPH [clinicaltrials:NCT00064649]Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia [clinicaltrials:NCT00077012]clinicaltrials:NCT00090103Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice [clinicaltrials:NCT00111592]Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) [clinicaltrials:NCT00116571]A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) [clinicaltrials:NCT00127179]Kinetics of the Finasteride Prostate Induced Apoptosis [clinicaltrials:NCT00130767]Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH) [clinicaltrials:NCT00143221]Laser Prostatectomy Database and Registry [clinicaltrials:NCT00159406]Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) [clinicaltrials:NCT00169585]Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate [clinicaltrials:NCT00169767]Questioning Patients About Adverse Medical Events: A Randomized Controlled Trial [clinicaltrials:NCT00187616]clinicaltrials:NCT00194675Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP) [clinicaltrials:NCT00199550]clinicaltrials:NCT00224107clinicaltrials:NCT00224120clinicaltrials:NCT00224133Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia [clinicaltrials:NCT00237536]Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED) [clinicaltrials:NCT00256399]Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP) [clinicaltrials:NCT00274417]ALF-ONE : ALFuzosin ONcE Daily [clinicaltrials:NCT00280605]clinicaltrials:NCT00284518ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH [clinicaltrials:NCT00290030]Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection [clinicaltrials:NCT00303654]Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS [clinicaltrials:NCT00316732]Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH [clinicaltrials:NCT00347061]Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH [clinicaltrials:NCT00359905]A Prospective Evaluation of the GreenLight Model 120 Laser [clinicaltrials:NCT00364585]clinicaltrials:NCT00368979Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer [clinicaltrials:NCT00375765]A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. [clinicaltrials:NCT00379067]Study of the Effects of Pomegranate Tablets on Enlarged Prostates [clinicaltrials:NCT00381108]Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H) [clinicaltrials:NCT00382356]clinicaltrials:NCT00384930
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Prostatic Hyperplasia [clinicaltrials_resource:65576df4c137eb00cbf79efe3af11147]
Bio2RDF identifier
65576df4c137eb00cbf79efe3af11147
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:65576df4c137eb00cbf79efe3af11147
identifier
clinicaltrials_resource:65576df4c137eb00cbf79efe3af11147
title
Prostatic Hyperplasia
@en
type
label
Prostatic Hyperplasia [clinicaltrials_resource:65576df4c137eb00cbf79efe3af11147]
@en
Prostatic Hyperplasia